Glutamine Regulates Skeletal Muscle Immunometabolism in Type 2 Diabetes.

"Duality of Interest. The costs of the human metabolomic study were supported by a grant from Daiichi Sankyo Co., Ltd. J.H. is an employee of Daiichi Sankyo Co., Ltd. No other potential conflicts of interest relevant to this article were reported."

"Funding. This work was supported by grants from the Swedish Research Council (2015-00165 and 2018-02389), the Novo Nordisk Foundation (Tripartite Immuno-metabolism Consortium grant NNF15CC0018486, MSAM Consortium grant NNF15SA0018346, and MeRIAD Consortium grant 0064142), the European Foundation for the Study of Diabetes Research Programme on New Targets for Type 2 Diabetes supported by an educational research grant from MSD, the Swedish Diabetes Foundation (DIA2018-357 and DIA2018-336), Diabetes Wellness, the Knut and Alice Wallenberg Foundation (2018-0094) (M.R., A.K, E.N., and J.R.Z.), Cimed (M.R.), the European Association for the Study of Diabetes/Novo Nordisk Foundation (NNF21SA0072747) (N.J.P.), the Strategic Research Programme in Diabetes at Karolinska Institutet (2009-1068), and the Stockholm County Council (SLL20170159). L.D. was supported by a Novo Nordisk postdoctoral fellowship run in partnership with Karolinska Institutet and by a Novo Nordisk Foundation postdoctoral fellowship for research abroad (NNF20OC0060969). J.R.Z., J.T., and E.D. were supported by the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR). CBMR is an independent Research Center at the University of Copenhagen that is partially funded by an unrestricted donation from the Novo Nordisk Foundation (NNF18CC0034900)."